BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10603649)

  • 1. [Molecular therapy in malignant tumors].
    Fey MF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1758-63. PubMed ID: 10603649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
    Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.
    Liu BL; Robinson M; Han ZQ; Branston RH; English C; Reay P; McGrath Y; Thomas SK; Thornton M; Bullock P; Love CA; Coffin RS
    Gene Ther; 2003 Feb; 10(4):292-303. PubMed ID: 12595888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of tumour suppressor gene expression for cancer.
    Roth JA
    Forum (Genova); 1998; 8(4):368-76. PubMed ID: 9863031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary cancer and its clinical implications: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; De Graaf PW; Derkinderen DJ; Hill FW; Huber J; Klein WR
    Anticancer Res; 1990; 10(2B):489-95. PubMed ID: 2190527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
    Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic gene therapy for cancer.
    Hargest R; Williamson R
    Gene Ther; 1996 Feb; 3(2):97-102. PubMed ID: 8867857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic gene therapy. Present situation and future perspective.
    Gottschalk U; Chan S
    Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes.
    Gordon EM; Chan MT; Geraldino N; Lopez FF; Cornelio GH; Lorenzo CC; Levy JP; Reed RA; Liu L; Hall FL
    Int J Oncol; 2007 Jun; 30(6):1297-307. PubMed ID: 17487349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current strategies in cancer gene therapy.
    El-Aneed A
    Eur J Pharmacol; 2004 Sep; 498(1-3):1-8. PubMed ID: 15363969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 tumor suppressor gene therapy for cancer.
    Nielsen LL; Maneval DC
    Cancer Gene Ther; 1998; 5(1):52-63. PubMed ID: 9476967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the biological therapy and gene therapy of malignant disease.
    Hersh EM; Stopeck AT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2623-9. PubMed ID: 10068264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bacteria in anti-cancer therapies.
    Ryan RM; Green J; Lewis CE
    Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer gene therapy: strategies and clinical trials.
    Prados J; Melguizo C; Boulaiz H; Marchal JA; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):23-36. PubMed ID: 16171562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene replacement strategies for cancer.
    Roth JA
    Isr J Med Sci; 1996 Feb; 32(2):89-94. PubMed ID: 8631656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells as vehicles for therapeutic genes to treat liver diseases.
    Prieto J; Fernandez-Ruiz V; Kawa MP; Sarobe P; Qian C
    Gene Ther; 2008 May; 15(10):765-71. PubMed ID: 18385768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell cycle and cancer--from the tumor cell line to the patient].
    Fey MF
    Praxis (Bern 1994); 2000 Mar; 89(11):435-7. PubMed ID: 10758729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.